Member Login
  1. Stocks
    2. /
  2. Renalytix AI plc (LSE: RENX)
    3. /

LSE:RENX (Renalytix AI plc)

About RENX

Renalytix (LSE: RENX) (OTCQB: RNLXY) is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes. Renalytix has received FDA approval and Medicare reimbursement for kidneyintelX.dkd which is now offered commercially in the United States.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Renalytix AI plc (LSE: RENX) Latest News

Investing Articles

Why has the Renalytix AI share price jumped?

| Christopher Ruane

On Thursday, the Renalytix AI share price grew by double digits. Christopher Ruane explains why and what he'll do on…

Read more »

Investing Articles

£500 to invest? Here’s how I’d look to make a 1,000% return investing in shares

| Andy Ross

Investing in shares can be hugely rewarding. To make big returns Andy Ross looks to smaller, more agile companies.

Read more »

Investing Articles

The Renalytix share price more than doubled in a year: what I’d do now

| Christopher Ruane

The Renalytix share price more than doubled in a year -- I know what I'll do now.

Read more »

Investing Articles

The price of this UK tech share is up over 80% in just the last month. Would I buy?

| Andy Ross

This UK tech share, which provides artificial intelligence diagnostics, has leapt recently in price and there could be potentially a…

Read more »